Prevalence of Multidrug-Resistant Tuberculosis in HIV/Tuberculosis Co-Infected Patients
- Author:
Chan Mi LEE
1
;
Eunyoung LEE
;
Ji Hwan BANG
;
Sang-Won PARK
;
Wan Beom PARK
;
Myoung-don OH
;
Nam Joong KIM
Author Information
- Publication Type:Brief Communication
- From:Infection and Chemotherapy 2021;53(4):792-795
- CountryRepublic of Korea
- Language:English
- Abstract: Tuberculosis (TB) is a common opportunistic infection in human immunodeficiency virus (HIV)-infected patients. Patients with multidrug-resistant (MDR)-TB have poor outcomes.This study aimed to determine the prevalence of MDR-TB in HIV/TB co-infected patients in the Korea. We reviewed the medical records of HIV/TB co-infected patients at two university hospitals between January 1998 and December 2020. During the study period, a total of 87 HIV/TB co-infected patients were identified, and drug susceptibility test results were available for 44 of them. The prevalence of MDR-TB in the study population was 15.9% (7/44, 95% confidence interval, 5.1 - 26.7).
